# Peruvian Chanchamayo Coffee (Coffea arabica 'Peruvian Chanchamayo')

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/peruvian-chanchamayo-coffee
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 2 / 10
**Category:** Coffee Cultivars
**Also Known As:** Coffea arabica 'Peruvian Chanchamayo', Chanchamayo coffee, Peruvian Chanchamayo arabica, Chanchamayo Valley coffee, Peruvian high-altitude arabica, Chanchamayo wet-processed coffee

## Overview

Peruvian Chanchamayo coffee is a Coffea arabica cultivar grown in Peru's Chanchamayo Valley, containing caffeine and chlorogenic acids as its primary bioactive compounds. These compounds act via adenosine receptor antagonism and [antioxidant](/ingredients/condition/antioxidant) pathways respectively, though no cultivar-specific clinical research exists to distinguish it from other arabica varieties.

## Health Benefits

• No specific health benefits documented - No clinical trials or studies have been conducted on this particular cultivar
• General coffee benefits may apply - Standard Coffea arabica contains caffeine and polyphenols, but no Chanchamayo-specific data exists
• No evidence of therapeutic properties - Sources indicate it is valued for sensory qualities rather than medicinal applications
• No traditional medicinal use documented - No evidence found in Andean or Amazonian traditional medicine systems
• Research limited to flavor profile - Current literature focuses only on taste characteristics, not health outcomes

## Mechanism of Action

Caffeine, the primary bioactive compound in Coffea arabica including Chanchamayo, competitively antagonizes adenosine A1 and A2A receptors in the central nervous system, reducing neural inhibition and increasing [dopamine](/ingredients/condition/mood) and norepinephrine signaling. Chlorogenic acids, particularly 5-caffeoylquinic acid, inhibit glucose-6-phosphatase and slow intestinal glucose absorption, while also scavenging [reactive oxygen species](/ingredients/condition/antioxidant) via phenolic hydroxyl groups. These mechanisms are inferred from general Coffea arabica research; no studies have isolated or quantified the specific phytochemical profile of the Chanchamayo cultivar.

## Clinical Summary

No clinical trials, observational studies, or pharmacological analyses have been conducted specifically on the Peruvian Chanchamayo coffee cultivar. Any potential health effects must be extrapolated from the broader Coffea arabica literature, which includes large prospective cohort studies such as the EPIC cohort (>500,000 participants) associating general coffee consumption with reduced risks of type 2 diabetes and liver disease. Because cultivar-specific phytochemical concentrations of caffeine and chlorogenic acids can vary meaningfully based on altitude, soil, and processing, these extrapolations carry significant uncertainty. The overall evidence base for this specific cultivar must be characterized as absent.

## Nutritional Profile

Based on standard Coffea arabica composition (no Chanchamayo-specific nutritional data exists; values reflect typical arabica green/roasted bean profile): Macronutrients per 100g roasted ground coffee — Protein: 10–13g (containing all essential amino acids, though extraction into brewed cup is minimal, <0.1g per 240ml serving); Fat: 15–17g (predominantly triglycerides, with coffee oil containing diterpenes cafestol and kahweol at ~0.5–1.0% by weight — largely retained in unfiltered preparations); Carbohydrates: 28–32g (mostly non-digestible polysaccharides and fiber; soluble fiber ~1.5–2.0g extracted per cup); Dietary fiber: 33–40g total. Bioactive compounds (per 240ml brewed cup): Caffeine: 80–120mg (arabica typically lower than robusta; Peruvian high-altitude arabicas often yield 1.2–1.4% caffeine in green bean); Chlorogenic acids (CGA): 70–200mg per cup (primary phenolic [antioxidant](/ingredients/condition/antioxidant)s; 5-caffeoylquinic acid dominant; bioavailability ~30–40% absorbed in small intestine); Trigonelline: 60–100mg (precursor to niacin/B3 upon roasting; medium roast yields ~1mg niacin equivalent per cup); Cafestol and kahweol: negligible in paper-filtered brew (<0.2mg), elevated in French press or espresso (2–4mg combined). Micronutrients per 240ml brewed cup: Potassium: 116mg (~3% DV); Magnesium: 7mg (~2% DV); Niacin (B3): 0.5–1.0mg from trigonelline degradation; Riboflavin (B2): 0.2mg; Manganese: 0.05mg; Phosphorus: 7mg. Polyphenol content: Total polyphenols estimated 200–550mg per cup (gallic acid equivalents); melanoidins formed during roasting contribute additional antioxidant capacity (~25–30% of total). High-altitude Chanchamayo growing conditions (1,200–1,800m) are associated with slower bean maturation, potentially yielding slightly higher sucrose content (6–9% green bean) and elevated aromatic precursors, though no peer-reviewed comparative nutritional analysis versus other arabica origins has been published. Bioavailability note: CGAs are partially degraded during roasting (light roast retains ~70%, dark roast ~30%); remaining CGAs show moderate bioavailability with peak plasma levels 1–2 hours post-consumption.

## Dosage & Preparation

No clinically studied dosage ranges are available for Peruvian Chanchamayo Coffee. The product is consumed as whole roasted beans or brewed coffee without standardization to specific compounds. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

As a Coffea arabica product, Chanchamayo coffee carries the standard safety profile of caffeinated beverages, including risks of [insomnia](/ingredients/condition/sleep), tachycardia, anxiety, and gastrointestinal upset at high doses, typically above 400 mg caffeine per day in healthy adults. Caffeine is a substrate and inhibitor of CYP1A2 and may interact with stimulant medications, certain antibiotics such as ciprofloxacin, and anticoagulants including warfarin by altering drug [metabolism](/ingredients/condition/weight-management). Pregnant individuals are generally advised to limit caffeine intake to under 200 mg per day due to associations with adverse fetal outcomes including low birth weight. Individuals with cardiac arrhythmias, anxiety disorders, or gastroesophageal reflux disease should exercise caution with any caffeinated coffee product.

## Scientific Research

No clinical trials, RCTs, or meta-analyses specific to Peruvian Chanchamayo Coffee have been conducted. No PMIDs are available as no studies isolating this cultivar variant were identified in PubMed or other scientific databases.

## Historical & Cultural Context

No evidence of historical or traditional medicinal use for Peruvian Chanchamayo Coffee was found in any traditional medicine systems. The cultivar is primarily recognized as a gourmet beverage coffee valued for its sensory qualities.

## Synergistic Combinations

Not applicable - no synergistic ingredients studied

## Frequently Asked Questions

### What makes Peruvian Chanchamayo coffee different from other arabica coffees?

Chanchamayo coffee is grown in Peru's central jungle region at elevations between 1,000 and 1,800 meters, conditions that generally favor higher concentrations of chlorogenic acids and a more complex aromatic profile due to slower bean maturation. However, no published phytochemical analysis has formally compared Chanchamayo's caffeine or polyphenol content against other arabica cultivars. Its differentiation is currently defined by geographic origin and flavor profile rather than documented biochemical distinctions.

### Does Peruvian Chanchamayo coffee have more antioxidants than regular coffee?

There is no peer-reviewed data quantifying the antioxidant content, specifically chlorogenic acid or caffeic acid concentrations, of Chanchamayo coffee relative to other arabica varieties. High-altitude arabica coffees as a general class tend to exhibit elevated polyphenol levels, which may apply here, but this remains speculative without cultivar-specific laboratory analysis. Consumers should not assume superior antioxidant activity based on geographic origin alone.

### How much caffeine is in Peruvian Chanchamayo coffee?

No published laboratory analysis has reported the specific caffeine content of Chanchamayo coffee beans. Coffea arabica species generally contain between 0.9% and 1.7% caffeine by dry weight, yielding approximately 80 to 120 mg of caffeine per 8-ounce brewed cup depending on roast level, grind size, and brewing method. Until cultivar-specific data is published, these general arabica ranges represent the best available estimate.

### Is Peruvian Chanchamayo coffee safe to drink every day?

Daily consumption of Chanchamayo coffee carries the same safety considerations as any caffeinated arabica coffee, with the FDA and EFSA both identifying 400 mg of caffeine per day as a generally safe upper limit for healthy adults. Regular intake above this threshold is associated with dependence, withdrawal headaches, elevated blood pressure, and sleep disruption. Individuals sensitive to caffeine, pregnant, or taking CYP1A2-metabolized medications should consult a healthcare provider before daily use.

### Are there any clinical studies on Peruvian Chanchamayo coffee specifically?

As of the current date, no clinical trials, randomized controlled studies, or published pharmacological investigations have examined Peruvian Chanchamayo coffee as a distinct cultivar. All potential health inferences must be drawn from the extensive general Coffea arabica literature, which itself varies significantly in quality and applicability. Researchers interested in this cultivar would need to conduct phytochemical profiling and controlled human studies before any evidence-based health claims could be made.

### What is the origin and growing region of Peruvian Chanchamayo coffee?

Peruvian Chanchamayo coffee is grown in the Chanchamayo Valley located in the Junín region of Peru's central highlands, at elevations between 1,200-1,800 meters. This specific microclimate and altitude contribute to the coffee's distinctive flavor profile characterized by balanced acidity, mild body, and subtle fruity and floral notes. The region's rich volcanic soil and consistent rainfall create ideal conditions for arabica cultivation.

### How does Peruvian Chanchamayo coffee compare to other Peruvian coffee varieties?

Peruvian Chanchamayo is distinguished from other Peruvian coffees like those from the Cusco or Huancayo regions by its specific terroir and processing methods, resulting in a smoother, more refined cup with lower acidity. While all Peruvian arabicas share general coffee constituents like caffeine and polyphenols, Chanchamayo is valued primarily for its sensory characteristics rather than unique chemical composition. The cultivar produces a more balanced, versatile coffee suitable for multiple brewing methods compared to more intensely flavored Peruvian regional variants.

### Is Peruvian Chanchamayo coffee suitable for people sensitive to caffeine?

Peruvian Chanchamayo coffee contains standard arabica caffeine levels (approximately 95mg per 8oz cup), making it no more suitable for caffeine-sensitive individuals than other arabica varieties. People with caffeine sensitivity should consider limiting consumption or choosing decaffeinated versions, as the cultivar offers no inherent reduction in caffeine content. Those with caffeine sensitivities may experience effects similar to any other standard coffee and should monitor their personal tolerance.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*